Conditions: Hepatitis C
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 448
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the rates of sustained virologic response in each cohort (Black-African Americans, Latinos) in this study to historical rate.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Daclatasvir intervention 2: Peg-Interferon Alfa-2a intervention 3: Ribavirin
Intervention descriptions: intervention 1: Tablet, Oral, 60 mg, once daily, 24 weeks intervention 2: Syringe, Subcutaneous Injection, 180 μg, Once weekly, 24 or 48 weeks depending on response intervention 3: Tablet, Oral, 1000 or 1200 mg based on weight, Twice daily, 24 or 48 weeks depending on response

Protocol document: